Gilead

Gilead

Biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases
Foster City United States (HQ)
Deals in the last 12 months undisclosed
Unicorns in portfolio: Kite Pharma, Forty Seven, Pharmasset

Gilead Company information

Edit
Launch date
Employees
5001-10000 people
Market cap
$78.8b
Net debt
$3.1b
Firm valuation
€74.5b (Public information from 2020)
USD20162017201820192020E2021E2022E
Revenues-26.1b22.1b22.4b24.1b23.4b23.1b
% growth--(15 %)1 %7 %(3 %)(1 %)
EBITDA-17.3b12.8b12.5b12.8b12.3b11.5b
% EBITDA margin-66 %58 %56 %53 %53 %50 %
Profit-4.6b5.5b5.4b2.4b7.4b6.9b
% profit margin-18 %25 %24 %10 %32 %30 %
EV / Revenue-4.6x3.5x3.7x3.4x3.4x3.4x
EV / EBITDA-6.9x6.1x6.6x6.4x6.5x6.8x
  • Edit
DateInvestorsAmountRound
-N/A
N/AN/AIPO
Total Funding-

Recent News about Gilead

Edit
Lists
LocationEdit
United States, Foster City, Lakeside Dr, 333
Investments analysisEdit

Investments by Gilead

Edit